Healthgen Biotech to attend KOREA PHARM & BIO 2026

Healthgen Biotech will participate in KOREA PHARM & BIO 2026, which takes place in Gyeonggi-do from 31th March to 3rd April.

Exhibition:  KOREA PHARM & BIO 2026

Location: KINTEX 2 (Korea International Exhibition Center 2), Korea

Time: 31th Mar--3rd Apr

Booth No.: 7G205

About KOREA PHARM & BIO

KOREA PHARM & BIO is Korea’s leading exhibition and conference dedicated to the pharmaceutical and bio-health industry.

As the industry undergoes rapid transformation-driven by digitalization, precision medicine, and global collaboration-KOREA PHARM & BIO 2026 provides the essential platform to explore the latest innovations and connect with key players across the entire value chain.

This exhibition is introducing the latest trends in the pharmaceutical & bio market, ranging from pharmaceuticals, APIs, Health ingredients, Bio-pharmaceuticals, smart healthcare, to contracts & outsourcing, pharmaceuticals & bio manufacturing, analytical equipment and bio-logstics & distributions.

About Healthgen

Healthgen offers recombinant HSA, TF, FN, and growth factors produced using a rice grain platform. These rice-derived recombinant proteins enhance safety, efficiency, stability, and cost-effectiveness for customers working with cell cultures, including iPSC, MSC, NK cell-based cell and gene therapies, viral vaccines, regenerative medicine, and drug delivery systems.

By participating, Healthgen aims to contribute to meaningful discussions on the future of biopharmaceutics and to share insights on how collaborative innovation can help bring novel raw materials to researcher safer.

Looking forward to meeting you in Korea.